PRIME MEDICINE INC. - COMMON STOCK

Prime Medicine to Participate in Upcoming Investor Conferences

28 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

20 фев 2024 16:01:00 Источник Nasdaq GlobeNewswire

Prime Medicine Announces Pricing of Upsized Public Offering

14 фев 2024 23:50:13 Источник Nasdaq GlobeNewswire

Prime Medicine Announces Proposed Public Offering of Common Stock

14 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis

25 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

05 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference

02 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine to Present at Upcoming Investor Conferences

08 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates

03 ноя 2023 16:01:00 Источник Nasdaq GlobeNewswire

Prime Medicine Presents First-ever Prime Editing Data in Non-human Primates Demonstrating Highly Efficient Ability of Prime Editors to Precisely Correct Disease-causing Mutation of GSD1b

27 окт 2023 06:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of Prime Editors to Treat Ophthalmological Diseases

24 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire

Prime Medicine to Highlight Positive Preclinical Developments Across Prime Editing Pipeline and Platform at Upcoming Industry Conferences

17 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine to Present at Upcoming Investor Conferences

19 сен 2023 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine to Present at Upcoming Investor Conferences

31 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates

07 авг 2023 16:01:00 Источник Nasdaq GlobeNewswire

Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs™ for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome

22 июн 2023 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine to Present at Investor Conferences in June

31 май 2023 08:00:00 Источник Nasdaq GlobeNewswire

Prime Medicine to Present at Virtual Investor Conferences in May

17 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting

17 май 2023 06:00:00 Источник Nasdaq GlobeNewswire